Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus

Veterinary Journal

Volumn 182, Issue 1, 2009, Pages 86-93

  Jas, D ^a   Aeberle C ^a   Lacombe, V ^a   Guiot, A L ^b   Poulet, H ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b Conseils en Pharmacie et Biologie ^*  (France)

Author keywords

Challenge; Feline calicivirus; Feline herpesvirus; Feline parvovirus; Vaccine

Indexed keywords

CALICIVIRUS VACCINE; HERPES VACCINE; PARVOVIRUS VACCINE; PUREVAX RCPCH FELV; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CAT DISEASE; CONTROLLED STUDY; DRUG EFFICACY; FELINE PANLEUKOPENIA VIRUS; HERPES VIRUS; INFECTION RESISTANCE; KITTEN; NONHUMAN; PROVOCATION TEST; SCORING SYSTEM; SEROCONVERSION; TREATMENT OUTCOME; VACCINATION; VESIVIRUS; VIRUS EXCRETION; VIRUS IMMUNITY;

ANIMALS; ANIMALS, NEWBORN; CALICIVIRIDAE INFECTIONS; CALICIVIRUS, FELINE; CAT DISEASES; CATS; FELINE PANLEUKOPENIA; FELINE PANLEUKOPENIA VIRUS; FEMALE; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; MALE; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES, ATTENUATED; VACCINES, COMBINED; VACCINES, INACTIVATED; VIRAL VACCINES;

ANIMALIA; FELID HERPESVIRUS 1; FELIDAE; FELINE CALICIVIRUS; FELINE PARVOVIRUS;

EID: 67349252499     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2008.05.025     Document Type: Article

References (21)

1. Coyne K.P., Jones B.R., Kipar A., Chantrey J., Porter C.J., Barber P.J., Dawson S., Gaskell R.M., and Radford A.D. Lethal outbreak of disease associated with feline calicivirus infection in cats. Veterinary Record 158 (2006) 544-550
2. Coyne K.P., Gaskell R.M., Dawson S., Porter C.J., and Radford A.D. Evolutionary mechanisms of persistence and diversification of a calicivirus within endemically infected natural host populations. Journal of Virology 81 (2007) 1961-1971
3. Dawson S., Mc Ardle F., Bennett D., Carter S.D., Bennett M., Ryvar R., and Gaskell R.M. Investigation of vaccine reactions and breakdowns after feline calicivirus vaccination. Veterinary Record 132 (1993) 346-350
4. Dawson S., Willoughby K., Gaskell R.M., Wood G., and Chalmers W.S. A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens. Journal of Feline Medicine and Surgery 3 (2001) 17-22
5. -vets.org>. pp. 1-15.
6. -vets.org>. pp. 1-17.
7. -vets.org>. pp. 1-23.
8. Gaskell R.M., Dawson S., and Radford A.D. Duration of immunity (DOI)-the regulatory issues. Veterinary Microbiology 117 (2006) 80-85
9. Gaskell R., Dawson S., Radford A., and Thiry E. Feline herpesvirus. Veterinary Research 38 (2007) 337-354
10. Glenn M., Radford A.D., Turner P.C., Carter M., Lowery D., DeSilver D.A., Meanger J., Baulch-Brown C., Bennett M., and Gaskell R.M. Nucleotide sequence of UK and Australian isolates of feline calicivirus (FCV) and phylogenetic analysis of FCVs. Veterinary Microbiology 67 (1999) 175-193
11. Kreutz L.C., Johnson R.P., and Seal B.S. Phenotypic and genotypic variation of feline calicivirus during persistent infection of cats. Veterinary Microbiology 59 (1998) 229-236
12. Lappin M.R., Sebring R.W., Porter M., Radecki S.J., and Veir J. Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleucopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1. Journal of Feline Medicine and Surgery 8 (2006) 158-163
13. Poulet H., Brunet S., Leroy V., and Chappuis G. Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges. Veterinary Microbiology 106 (2005) 17-31
14. Poulet H. Alternative early life vaccination programs for companion animals. Journal of Comparative Pathology 137 Suppl. 1 (2007) S67-S71
15. Povey R.C., and Wilson M.R. A comparison of inactivated feline viral rhinotracheitis and feline caliciviral disease vaccines with live-modified viral vaccines. Feline Practice 8 (1978) 35-42
16. Radford A.D., Bennett M., Mc Ardle F., Dawson S., Turner P.C., Glenn M.A., and Gaskell R.M. The use of sequence analysis of a feline calicivirus (FCV) hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures. Vaccine 15 (1997) 1451-1458
17. Radford A.D., Sommerville L., Ryvar R., Cox M.B., Johnson D.R., Dawson S., and Gaskell R.M. Endemic infection of a cat colony with a feline calicivirus closely related to an isolate used in live attenuated vaccines. Vaccine 19 (2001) 4358-4362
18. Radford A.D., Dawson S., Coyne K.P., Porter C.J., and Gaskell R.M. The challenge for the next generation of feline calicivirus vaccines. Veterinary Microbiology 117 (2006) 14-18
19. Schultz R.D. Duration of immunity for canine and feline vaccines: a review. Veterinary Microbiology 117 (2006) 75-79
20. Scott F.W., and Geissinger C.M. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine. American Journal of Veterinary Research 60 (1999) 652-658
21. Seal B.S., Ridpath J.F., and Mengeling W.L. Analysis of feline calicivirus capsid protein genes: identification of variable antigenic determinant regions of the protein. Journal of General Virology 74 (1993) 2519-2524